Literature DB >> 20054019

Should cetuximab replace cisplatin in head and neck cancer?

Karen Rowan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054019     DOI: 10.1093/jnci/djp531

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Emerging drugs to treat squamous cell carcinomas of the head and neck.

Authors:  Christopher Fung; Jennifer R Grandis
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 2.  Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma.

Authors:  Ana Markovic; Christine H Chung
Journal:  Expert Rev Anticancer Ther       Date:  2012-09       Impact factor: 4.512

3.  Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience.

Authors:  Alexandra D Jensen; Zazie P Bergmann; Helena Garcia-Huttenlocher; Kolja Freier; Jürgen Debus; Marc W Münter
Journal:  Head Neck Oncol       Date:  2010-11-26

4.  Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multicenter phase IV trial.

Authors:  G Habl; K Potthoff; M F Haefner; A Abdollahi; J C Hassel; E Boller; M Indorf; J Debus
Journal:  BMC Cancer       Date:  2013-07-15       Impact factor: 4.430

5.  Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial.

Authors:  Jian-Feng Huang; Fu-Zheng Zhang; Qin-Zhou Zou; Le-Yuan Zhou; Bo Yang; Jian-Jun Chu; Jia-Hua Yu; Hao-Wen Zhang; Xiao-Peng Yuan; Guo-Mei Tai; Fen-Ju Liu; C-M Charlie Ma
Journal:  Oncotarget       Date:  2017-01-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.